Dealmaker Q&A: Panopto’s Jason Beem on Acquiring Elai
This strategic acquisition targets expanded AI capabilities for the video management company
Sectors
2024 PE-Backed Holiday Gift Guide
From apparel to sports equipment to snacks, PE portfolio companies offer a range of gift options for the holiday season
Dealmaker Q&A: Kava Equity Partners on Acquiring Arrowhead Contracting
The recently launched PE fund, an entity of the Southern Ute Indian Tribe Growth Fund, plans to take a long view on investments that align with the Tribe’s values
A Recipe for Growth in Food Allergy Prevention
At the intersection of consumer and healthcare, food allergies have a massive addressable market—but plenty of complexities investors should consider
All Eyes on the Presidential Race
M&A experts weigh in on how election outcomes might impact dealmaking in the months ahead
Betting on the Face Card: Building out Aesthetic Healthcare Brands
Investors and advisors tracking med spas say there is ample opportunity for expansion and building platforms in a highly fragmented market comprised of small clinics
The Risks and Rewards of Investing in Women’s Healthcare
A panel hosted by ACG Chicago discussed regulatory changes, emerging technology and other trends shaping the women’s health vertical
AI Bears Doubt Its Promise to Deliver
Proponents say artificial intelligence will revolutionize many industries, including M&A—but skeptics say this AI revolution may not materialize
How Private Equity Can Respond to Foreign Investment Risks
In light of recent warnings on the risks of foreign investments, PE and VC firms must remain vigilant and proactive in safeguarding the sensitive information of their portfolio companies
Consumer M&A Muddles Through Amid Mixed Spending Habits
Dealmakers take a wait-and-see approach to consumer M&A, even as inflation cools and interest rates drop